Elagolix 150 mg, 200 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 150 mg, 200 mg

Reference Brands: Orilissa (USA),

Category: Women's Health

Elagolix is a Women's Health product available as Tablets in strengths 150 mg, 200 mg. It corresponds to the reference brands Orilissa (USA),. Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Elagolix, marketed under the brand name Orilissa, is an oral gonadotropin-releasing hormone (GnRH) antagonist used primarily for the management of moderate to severe pain associated with endometriosis in women. By selectively blocking GnRH receptors in the pituitary gland, elagolix reduces the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to a dose-dependent decrease in ovarian estrogen production. This reduction in estrogen helps alleviate endometriosis-related pelvic pain, dysmenorrhea, and other associated symptoms.

Elagolix is administered orally once or twice daily, with treatment duration ranging from 6 to 24 months depending on the prescribed dosage and therapeutic goals. Beyond its approved use for endometriosis, elagolix is also under development for the treatment of uterine fibroids and heavy menstrual bleeding in premenopausal women. Earlier clinical investigations explored its potential use in men for prostate cancer and benign prostatic hyperplasia; however, these development programs have been discontinued.

With its targeted mechanism of action and oral dosing, elagolix provides a convenient and effective option for long-term management of estrogen-dependent gynecological conditions, offering symptom relief while allowing flexibility in dosing and duration of therapy.